Most placebo-controlled trials in inflammatory bowel disease were underpowered because of overestimated drug efficacy rates: Results from a systematic review of induction studies.
暂无分享,去创建一个
Siddharth Singh | B. Kahan | V. Jairath | Christopher Ma | J. Hanžel | N. Narula | Lily Zou | Paul Bahnam